+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
Healthy Volunteers
ID04197921

Feasibility Study of Exablate Low Intensity Focused Ultrasound for Treating Opioid and Other Substance Use Disorders

Led by InSightec · Updated on 2026-06-26

29

Participants Needed

4

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of Low Intensity Focused Ultrasound LIFU with the Exablate4000 Type 2.02.1 device as an additional neuromodulatory treatment for Opioid Use Disorder OUD and other Substance Use Disorders SUDs. The study focuses on assessing the safety and tolerability of this treatment in people with OUD. This clinical trial is designed to explore how this device may help manage these conditions. Participants will undergo two treatment stages. In each stage, they will receive both a sham inactive and an active LIFU treatment, but they will not know which one they receive first. The first stage involves a moderate intensity LIFU procedure, while the second stage uses an enhanced intensity procedure. After each treatment, participants will be monitored for 90 days to assess any adverse events. Throughout the study, participants will be evaluated regularly for treatment-emergent adverse events from the time of the Exablate procedure through a four-month follow-up period. They will need to comply with study visits and report their sensations during the procedure. Safety and tolerability will be closely monitored, with participants expected to complete all study visits and assessments. The total participation time includes treatment stages and follow-up, ending no later than 2027.

CONDITIONS

Brief Title

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)

Research Team

K

Kingsley Nwaogu

J

Julia Zhu

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here